newsfilter
← Latest News
Business Wire·

Cybin Receives Final Approval to Commence Trading on the NYSE American on or About August 5

Cybin Inc. (NEO:CYBN) (OTCQB:CLXPF) ("Cybin" or the "Company"), a biotechnology company focused on progressing psychedelic therapeutics, today announced that it has received approval for the listing of its common shares on the NYSE American LLC stock ex